News
| 5 min read
Drug discovery still relies on destroying cells to understand how they respond, but new real-time measurement approaches are beginning to reveal biology in motion rather than in snapshots.
| 4 min read
Hidden proteins reveal new drug targets, FDA tool upgrades, pharma deals, and more led the news this week.
| 5 min read
Real-world data and late-stage trial results at DDW 2026 highlight persistent gaps in long-term IBD control despite therapeutic advances.
| 3 min read
New findings suggest that the location of mRNA expression in the body plays a critical role in shaping T cell responses, opening the door to more precise and effective mRNA-based treatments.
| 4 min read
A multicountry study shows that a point-of-care TB test performs comparably to established molecular diagnostics while offering a simpler workflow and faster turnaround.
| 4 min read
Researchers have identified a previously unrecognized inflammatory pathway driven by damaged mitochondria in pancreatic cancer cells, revealing a potential vulnerability.
| 4 min read
Real-time clinical trials, pharma deals, cancer found to be rising in young people, and more led the news this week.
| 5 min read
A single-batch bacterial system for producing nanobody cocktails could make snakebite treatment far more affordable and scalable.
| 6 min read
The compound reduced opioid intake within hours in rats and was linked to changes in synaptic organization and gene expression in reward-related brain regions.
| 5 min read
Researchers identified a mitochondrial enzyme that shields lung cancer cells from a radiation-induced cell death process — and then found that an existing arthritis drug can disable that shield.
| 4 min read
Researchers have identified a distinctive gut microbiome pattern linked to Parkinson’s disease that appears in both diagnosed patients and a subset of symptom-free individuals who may already be on a disease trajectory.
| 4 min read
Executive orders, AI drug discovery models, pharmaceutical deals, and more led the news this week.
